Eureka Forbes Ltd
NSE: EUREKAFORB BSE: 543482
Eureka Forbes Limited is India’s leading health and hygiene brand. Its product portfolio encompasses water purification, vacuum cleaning and air purification.[1]
₹502
52W: ₹355 — ₹668
PE 49.7 · Book ₹232 · +116% vs bookMarket Cap₹9,714 Cr
Stock P/E49.7Price to Earnings
ROCE5.04%Return on Capital
ROE3.69%Return on Equity
Div. Yield0%Face Value ₹10
Strengths
- +Company is almost debt free.
- +Company has delivered good profit growth of 183% CAGR over last 5 years
Weaknesses
- −Though the company is reporting repeated profits, it is not paying out dividend
- −Company has a low return on equity of 2.30% over last 3 years.
- −Promoters have pledged 53.7% of their holding.
- −Promoter holding has decreased over last 3 years: -10.0%
Shareholding Pattern
Promoters62.56%
FIIs13.66%
DIIs6.16%
Public16.77%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 62.56% | 62.56% | 62.56% | 62.56% | 62.56% | 62.56% | 62.56% | 62.56% |
| FIIs | 13.21% | 12.62%▼0.6 | 12.56%▼0.1 | 12.53%▼0.0 | 14%▲1.5 | 13.72%▼0.3 | 13.87%▲0.1 | 13.66%▼0.2 |
| DIIs | 6.3% | 6.67%▲0.4 | 6.6%▼0.1 | 7.01%▲0.4 | 6.35%▼0.7 | 6.38%▲0.0 | 6.45%▲0.1 | 6.16%▼0.3 |
| Public | 17.08% | 17.29%▲0.2 | 17.41%▲0.1 | 17.03%▼0.4 | 16.23%▼0.8 | 16.48%▲0.3 | 16.27%▼0.2 | 16.77%▲0.5 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 592.31 | 538.57 | 553.07 | 552.81 | 672.87 | 597.84 | 612.54 | 607.74 | 773.45 | 645.45 |
| Expenses | 541.08 | 496.4 | 500.41 | 498.09 | 601.04 | 539.14 | 534.89 | 546.49 | 677.59 | 578.01 |
| Operating Profit | 51.23 | 42.17 | 52.66 | 54.72 | 71.83 | 58.7 | 77.65 | 61.25 | 95.86 | 67.44 |
| OPM % | 8.65% | 7.83% | 9.52% | 9.9% | 10.68% | 9.82% | 12.68% | 10.08% | 12.39% | 10.45% |
| Net Profit | 25.47 | 22.64 | 21.37 | 31.04 | 46.67 | 34.82 | 50.75 | 38.52 | 61.59 | 9 |
| EPS ₹ | 1.32 | 1.17 | 1.11 | 1.61 | 2.41 | 1.8 | 2.62 | 1.99 | 3.18 | 0.47 |
AI Insights
Revenue Trend
TTM revenue at ₹2,639Cr, up 8.3% YoY. OPM at 11%.
Debt Position
Borrowings at ₹91Cr. Debt-to-equity ratio: 0.02x. Healthy balance sheet.
Capex Cycle
CWIP at ₹4Cr (0% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 6.16% (+3.43pp change). FIIs: 13.66% (+2.90pp change). Promoters hold 62.56%.
Margin & Efficiency
ROCE improving from 0% (Mar 2013) to 5% (Mar 2025). Working capital days: -71.
Valuation
PE 49.7x with 5.04% ROCE. Price is 116% above book value of ₹232. Dividend yield: 0%.
Recent Announcements
- Intimation For Earning Conference Call - Financial Results For The Quarter And Financial Year Ended March 31, 2026 13 May - Eureka Forbes schedules Q4 FY26 and FY26 earnings call on May 20, 2026 at 2:00 PM IST.
- Board Meeting Intimation for Considering And Approving Audited Standalone And Consolidated Financial Statements And Results Of The Company For The Quarter And Financial Year Ended March 31, 2026. 13 May - Board meeting on May 19, 2026 to approve audited Q4 and FY26 standalone and consolidated results.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 13 Apr - The Certificate received from MUFG Intime India Private Limited under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026.
- Closure of Trading Window 25 Mar - Eureka Forbes: Trading window closed April 1, 2026 until 48 hours after FY2026 results; board date TBA.
- Intimation Of Schedule Of Analyst/Institutional Investor Meeting Under Regulation 30 Of SEBI LODR 19 Mar - Non-deal roadshow in Singapore on Mar 24-25, 2026; may present Q3FY26/Investor Day.
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse